Philip M Robson, PhD
Dr. Robson is an Instructor of Radiology in the BioMedical Engineering and Imaging Institute (BMEII) and is a member of the Cardiovascular Imaging group. Dr. Robson’s research includes the development of hybrid positron emission tomography (PET) magnetic resonance (MR) imaging technology and its applications in cardiovascular disease, including coronary and carotid artery disease, cardiac sarcoidosis and other cardiomyopathies. His work has led to some of the first successful applications of imaging the activity of micro-calcification and inflammation in atherosclerotic plaque in the coronary arteries using 18F-fluoride and 18F-FDG PET/MR imaging and the development of combined PET and MR protocols for evaluating cardiac sarcoidosis and amyloidosis. He is currently working on methods for MR-based motion correction of PET data, MR-based attenuation correction and complementary anatomical and functional cardiac MR imaging for optimizing cardiac and coronary PET/MR imaging. Dr. Robson’s research includes partnerships with clinical investigators in the Cardiovascular Institute as well as national and international collaborators. Before joining Mount Sinai, Dr. Robson worked as a postdoctoral fellow at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, MA. He was awarded doctoral and undergraduate degrees in Physics by the University of Cambridge, UK.
Atherosclerosis, Cardiovascular, Imaging, MRI, Magnetic Resonance Imaging, Positron Emission Tomography